 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 1 | 1/1 | 返回列表 |
| 查看: 417 | 回復(fù): 0 | |||
liushuai8608木蟲 (小有名氣)
|
[求助]
醫(yī)學(xué)臨床實驗設(shè)計
|
|
42. ADIPOA - Clinical Study. 1) Agency &Identifier Agency: University Hospital, Montpellier (First received: March 19, 2012 Last updated: December 3, 2014 Last verified: December 2014) Identifier： 2) Purpose Primary: To study the safety of a single injection of autologous adipose derived mesenchymal stromal cells (ASCs) on patients with moderate or severe osteoarthritis of the knee (OA). Secondary: To study the efficacy of a single injection of autologous adipose derived mesenchymal stromal cells on patients with moderate or severe osteoarthritis of the knee (OA). Condition Intervention Phase Osteoarthritis Biological: Autologous adipose derived stem cells administrated for intra-articular use Phase 1 Arms Assigned Interventions Experimental: Group 1 2 x 10E6 ASC intra-articular injection (5 ml) Biological: Autologous adipose derived stem cells administrated for intra-articular use Each patient will receive one single administration of the cells and will be followed for 3 months. Each patients will be follow-up during one year with routinely examinations for safety issues. The first patient will be followed during 12 weeks before inclusion of the second patient. Experimental: Group 2 10 x 10E6 ASC intra-articular injection (5 ml) Biological: Autologous adipose derived stem cells administrated for intra-articular use Each patient will receive one single administration of the cells and will be followed for 3 months. Each patients will be follow-up during one year with routinely examinations for safety issues. Experimental: Group 3 50 x 10E6 ASC intra-articular injection (5 ml) Biological: Autologous adipose derived stem cells administrated for intra-articular use Each patient will receive one single administration of the cells and will be followed for 3 months. Each patients will be follow-up during one year with routinely examinations for safety issues. 3) Criteria Inclusion Criteria: OA diagnosis should fulfil the criteria of the American College of Rheumatology (ACR) with moderate or severe medial and/ or external femorotibial knee osteoarthritis (OA) (stage 3 or 4) and indication total knee arthroplasty. Exclusion Criteria: Any disease or medication affecting the bone or cartilage metabolism, including corticoids. 4) Outcome Measures Primary Outcome Measures: • Recording of Serious Adverse Events [ Time Frame: during 365 days following injection ] [ Designated as safety issue: Yes ] Adverse events will be described with respect to seriousness, intensity, relationship to treatment, action taken and outcome of the adverse event. Secondary Outcome Measures: • Functional status of the knee [ Time Frame: during 365 days following injection ] [ Designated as safety issue: Yes ] Efficacy will be assessed by measuring: o WOMAC (Western Ontario and McMaster Universities osteoarthritis index), o Short Arthritis assessment Scale (SAS), o range of motion of the target knee joint, o imaging through MRI evaluation, dGEMRIC and T1rho MRI. • Quality of life [ Time Frame: during 365 days following injection ] [ Designated as safety issue: No ] Quality of life will be assessed by measuring: o pain-specific assessment o global patient assessment (visual analog scale, Short-Form 8) o decrease in rescue paracetamol medication. |
回復(fù)此樓» 猜你喜歡
合肥區(qū)域性重點一本招收調(diào)劑
已經(jīng)有4人回復(fù)
-
085600材料與化工調(diào)劑
已經(jīng)有10人回復(fù)
-
22408 359分調(diào)劑
已經(jīng)有7人回復(fù)
-
297求調(diào)劑
已經(jīng)有4人回復(fù)
-
085602化工求調(diào)劑（331分）
已經(jīng)有8人回復(fù)
-
307求調(diào)劑
已經(jīng)有18人回復(fù)
-
085701環(huán)境工程求調(diào)劑
已經(jīng)有12人回復(fù)
-
288資源與環(huán)境專碩求調(diào)劑，不限專業(yè)，有學(xué)上就行
已經(jīng)有11人回復(fù)
-
一志愿華東師范大學(xué)有機化學(xué)專業(yè)，初試351分，復(fù)試被刷求調(diào)劑!
已經(jīng)有8人回復(fù)
-
266分，求材料相關(guān)專業(yè)調(diào)劑
已經(jīng)有7人回復(fù)
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 liushuai8608 的主題更新
| 1 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 285求調(diào)劑 +6 | AZMK 2026-03-29 | 9/450 |
|
|---|---|---|---|---|
|
[考研] 一志愿華中師范化學(xué)332分求調(diào)劑 +3 | Lyy930824@ 2026-03-29 | 3/150 |
|
|
|
[考研] 一志愿北京化工大學(xué)材料與化工（085600）296求調(diào)劑 +25 | 稻妻小編 2026-03-26 | 25/1250 |
|
|
|
[考研] 334分 一志愿武理 材料求調(diào)劑 +16 | 李李不服輸 2026-03-26 | 16/800 |
|
|
|
[考研] 329求調(diào)劑 +8 | 星野? 2026-03-26 | 8/400 |
|
|
|
[考研] 283求調(diào)劑（080500） +14 | A child 2026-03-27 | 14/700 |
|
|
|
[考研] 材料與化工272求調(diào)劑 +21 | 阿斯蒂芬2004 2026-03-28 | 21/1050 |
|
|
|
[考研] 317求調(diào)劑 +10 | 蛋黃咸肉粽 2026-03-26 | 10/500 |
|
|
|
[考研] 279求調(diào)劑 +4 | 蝶舞輕繞 2026-03-29 | 4/200 |
|
|
|
[考研] 調(diào)劑求院校招收 +6 | 鶴鯨鴿 2026-03-28 | 6/300 |
|
|
|
[考研] 330分求調(diào)劑 +5 | qzenlc 2026-03-29 | 5/250 |
|
|
|
[考研] 071000生物學(xué)求調(diào)劑，初試成績343 +7 | 小小甜面團 2026-03-25 | 7/350 |
|
|
|
[考研] 286求調(diào)劑 +12 | PolarBear11 2026-03-26 | 12/600 |
|
|
|
[考研] 295求調(diào)劑 +5 | 1428151015 2026-03-27 | 6/300 |
|
|
|
[考研] 279 分 求調(diào)劑 +4 | 睡個好覺_16 2026-03-24 | 4/200 |
|
|
|
[考研] 總分322求生物學(xué)/生化與分子/生物信息學(xué)相關(guān)調(diào)劑 +5 | 星沉uu 2026-03-26 | 6/300 |
|
|
|
[考研] 085601求調(diào)劑總分293英一數(shù)二 +4 | 鋼鐵大炮 2026-03-24 | 4/200 |
|
|
|
[考研] 求調(diào)劑 +3 | 李李不服輸 2026-03-25 | 3/150 |
|
|
|
[考研] 292求調(diào)劑 +4 | 鵝鵝鵝額額額額?/a> 2026-03-24 | 4/200 |
|
|
|
[考研] 080500求調(diào)劑 +3 | zzzzfan 2026-03-24 | 3/150 |
|